Last Updated: April 22, 2021
Result type: Reports
Generic Name: apomorphine hydrochloride
Indications: Indicated for the acute, intermittent treatment of “OFF” episodes in patients with Parkinson's disease.
Last Updated: April 22, 2021
Result type: Reports
Generic Name: natalizumab
Indications: Tysabri (intravenous, IV; and subcutaneous, SC) is indicated as monotherapy for the treatment of patients with the relapsing-remitting form of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations, to decrease the number and volume of active brain lesions identified on magnetic resonance imaging (MRI) scans and to delay the progression of physical disability. Tysabri is generally recommended in MS patients who have had an inadequate response to, or are unable to tolerate, other therapies for multiple sclerosis.
Last Updated: April 22, 2021
Result type: Reports
Generic Name: alpelisib
Indications: Piqray (alpelisib), in combination with fulvestrant, is indicated for the treatment of postmenopausal women and men, with hormone receptor-positive, HER2-negative, PIK3CA mutated advanced or metastatic breast cancer after disease progression following an endocrine-based regimen.
Last Updated: April 22, 2021
Result type: Reports
Generic Name: macitentan and tadalafil
Indications: For the long-term treatment of pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) to reduce morbidity in patients of WHO functional class (FC) II or III whose PAH is either idiopathic or heritable or associated with connective tissue disease or congenital heart disease. Macitentan and tadalafil can be used in patients who are currently treated concomitantly with macitentan 10 mg and tadalafil 40 mg (20 mg x 2) as separate tablets.
Last Updated: December 23, 2020
Result type: Reports
Generic Name: dupilumab
Indications: Dupixent is indicated as an add-on maintenance treatment in patients aged 12 years and older with severe asthma with a type 2/eosinophilic phenotype or oral corticosteroid-dependent asthma.
Last Updated: December 22, 2020
Result type: Reports
Generic Name: risdiplam
Indications: For the treatment of spinal muscular atrophy (SMA) in patients 2 months and older.
Last Updated: December 22, 2020
Result type: Reports
Generic Name: satralizumab
Indications: ENSPRYNG (satralizumab) is indicated as monotherapy or in combination with immunosuppressive therapy (IST) for the treatment of neuromyelitis optica spectrum disorders (NMOSD) in adult and adolescent patients who are anti-aquaporin 4 (AQP4) seropositive. ENSPRYNG is not intended for acute treatment of an NMOSD relapse.
Last Updated: December 24, 2020
Result type: Reports
Generic Name: amifampridine
Indications: Indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 years of age and older.
Last Updated: December 23, 2020
Result type: Reports
Generic Name: infliximab
Indications: Use in combination with methotrexate for the reduction in signs and symptoms, inhibition of the progression of structural damage and improvement in physical function in adult patients with moderately to severely active rheumatoid arthritis.
Last Updated: December 21, 2020
Result type: Reports
Generic Name: encorafenib and binimetinib
Indications: Braftovi (encorafenib): In combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600 mutation, as detected by a validated test. Mektovi (binimetinib): In combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600 mutation, as detected by a validated test.
